Skip to main content
main-content

10-06-2021 | ASCO 2021 | Conference coverage | Video

Perspectives on the OlympiA study of adjuvant olaparib in early breast cancer

Nadine Tung provides an independent comment on the OlympiA study results, highlighting the importance of germline genetic testing and outlining the key questions raised by the findings (5:49).

Related content

2021 ASCO Annual Meeting coverage

Access news and expert commentary from the 2021 ASCO Annual Meeting

Image Credits